Discover B2B companies, suppliers, and manufacturers related to this keyword category
AOP Health is the European pioneer for integrated therapies for rare diseases and in critical care.
Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.
If you have kids, be glad you have Children's.
Driving change to defeat serious chronic diseases, built upon our heritage in diabetes.
We’re working to enable faster and deeper genomic diagnosis & research, to bring genomic healthcare to all who need it.
Pharmaceutical Company & Service Partner
Commercialization of innovative therapies in Central and Eastern Europe
The essential biodata life science partner for rare and neurodegenerative diseases
Navigating the Middle East & Africa to Broaden Patient Access, Faster
Better Bioinformatics For Everyone!
Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases.
Alone we are rare. Together we are strong.®
Scientific support for healthcare
Variantyx is a technology-driven precision medicine company providing state-of-the-art genomic testing.
BCDD is a fully integrated center for translational research providing support for early-stage drug discovery.
A clinical-stage international biotechnology research company focused on treatment innovation for mitochondrial disease
Developing innovative therapeutics for diseases at confluence of fibrosis and inflammation with high unmet need
Генетичната лаборатория осъществява високоспециализирана болнична и доболнична генетична помощ.
Powering the Future of Genetic Medicines
Working across borders and diseases to improve the lives of all people living with rare diseases.
We develop oral small-molecule and protein therapeutics to target complement-mediated and other rare diseases.
Imagine faster patient access to medicines and improved health outcomes with Clinerion real world data.
Making it accessible professional and quality service for pharmaceutical import and global outsourcing.
Clinical-stage biopharma company developing novel RNA-modulating drug candidates to treat rare and ultra rare diseases.
Open source and open access innovation in healthcare knowledge - a new publishing paradigm.
Transforming Lives, Every Day.
Providing relief to patients with unmet medical needs in select specialty and rare diseases.
Transforming Healthcare: Leading the Way in Pharmaceutical Sales, Marketing, Storage, and Distribution in Iraq.
INTERGEN Official Account (INTERGEN Resmi Hesabı)
Institut Imagine, pour guérir les maladies génétiques.
Developing Novel, First in Class Drug, Targeting Type 2 Diabetes, Based on a Core-Technology-Platform
We are the forefront of medical research, solving the greatest health problems facing our community.
Healthcare marketing specialists in CEE region.
Helping seriously ill children lead a more marvellous life.
Your trusted business partner for un-licensed & licensed medicines market in Turkey!
AI-Powered Clinical Research | Strategic & Synergetic Scaling™ | Data-Driven CRO Excellence
We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis
Developing best-in-class curative gene therapies for rare disorders.
India's Pioneering Genomics Company: Preventive Genomics (Genomepatri, MyFitGene, MedicaMap) + Clinical (WES, WGS etc)
Great Science Deserves Great People.
AI for Faster Rare Disease Diagnosis | Scalable PaaS Solutions for Hospitals & Pharma
AI for Faster Rare Disease Diagnosis | Scalable PaaS Solutions for Hospitals & Pharma
AI for Faster Rare Disease Diagnosis | Scalable PaaS Solutions for Hospitals & Pharma
AI for Faster Rare Disease Diagnosis | Scalable PaaS Solutions for Hospitals & Pharma
Improve diagnosis, treatment and care of people affected by rare neurological diseases in Europe.
Transforming life sciences with cutting-edge proteomics technology and solutions
Smart Clinical Operations. Tailored partnerships. Real results.
Face2Gene - Detecting Rare Disease Early with the Help of AI
Tenacious in our search for transformative therapies
Pharmaceutical and Healthcare Market Research Consultants
Developing and commercializing novel therapies for rare genetic skin diseases with no approved treatments.
Improving the accessibility to the ERNs by integrating them into the National Healthcare Systems
Lipotype is the leading lipidomics service provider.
Advancing our proprietary Axiomer™ RNA-editing platform technology
Approaching healthcare innovation with purpose and agility to deliver new breakthroughs for people facing disease.
Sleep and wakefulness, both of them, when immoderate constitute disease
Independent pharmacy offering specialized services, medications and treatments
European Reference Network (ERN) for rare urogenital diseases & complex conditions requiring highly-specialised surgery
Capricor (NASDAQ: CAPR) is a biotechnology company developing cell and exosome-based therapeutics for serious diseases.
Advancing a targeted approach to treat GRIN-related disorders and other pediatric neurodevelopmental disorders.
Pioneering a powerful new class of medicines based on red blood cell extracellular vesicles
Empresa biotecnológica en Sevilla basada en el desarrollo de herramientas de ayuda al diagnóstico.
Developing transformative gene therapies for patients suffering from severe rare diseases.
Dedicated to transforming the lives of patients with severe and other genetic diseases through innovative gene therapy.
Supply chain specialist for rare & orphan diseases' medicines in the pharmaceutical industry
Institut Imagine, pour guérir les maladies génétiques.
Until the cure of the rare disease of Pulmonary Hypertension we will be here to help any patient around the world
Our Vision : We have High Standards - We Build Companies - We have Impact
We create value in the field of medical diagnostics & biotechnology and move forward with innovative products.
Maximizing Your Brand’s Potential Through Data-Driven Solutions
A novel technology platform for the delivery of therapeutics across biological barriers
We're on a mission to help diagnosis and get new drug treatments into the hands of rare disease patients. Quickly.
Assessment and #Neurorehabilitation Platform for professionals featuring thousands of #CognitiveStimulation activitie
No rare journey alone. Previously known as Findacure.
We are on a global mission to establish gene therapy as a new standard of care for the leading causes of vision loss.
At Mendelian, rare diseases are our priority. We're enabling doctors to help patients earlier by finding the undiagnosed
Making promising innovations possible together
Committed to developing and commercializing long-acting treatments for patients with severe and chronic diseases.
Where creative thinking meets scientific excellence